MedTrace Logo

Effects of L-citrulline Supplementation on Vascular Function in Metabolic Syndrome

NCT06025357 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-05-15

No results posted yet for this study

Summary

The objective of this project is to provide evidence that L-Citrulline (CIT) supplementation can improve vascular function in the fasted and acute hyperglycemia conditions in middle-aged and older women with metabolic syndrome.

Conditions

Interventions

DIETARY_SUPPLEMENT

L-Citrulline supplementation

4 weeks of L-Citrulline supplementation (10 grams/day).

DIETARY_SUPPLEMENT

Placebo

4 weeks of microcrystalline Cellulose supplementation.

Sponsors & Collaborators

  • Texas Tech University

    lead OTHER

Principal Investigators

  • Arturo Figueroa · Texas Tech University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
79 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-05-01
Completion
2024-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06025357 on ClinicalTrials.gov